Video

Dr. O'Regan on Treatment of Breast Cancer in Premenopausal Women

Author(s):

Ruth O’Regan, MD, division head of Hematology and Oncology in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, discusses treatment for premenopausal patients with breast cancer.

Ruth O’Regan, MD, division head of Hematology and Oncology in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, discusses treatment for premenopausal patients with breast cancer.

Overall, only 20% of breast cancer occur in women who are still having regular periods, states O’Regan. Less than 10% occur in women of the age of 40 and less than 2% in women under the age of 35.

If one looks biologically what you find is that they are more likely to get triple-negative breast cancer (TNBC), explains O’Regan. They are less likely to get luminal A cancers. However, there are data demonstrating that as the age increases, the rate of TNBC goes down and the rate luminal A goes up.

Related Videos
Ruth M. O’Regan, MD
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Sheldon M. Feldman, MD
Dana Zakalik, MD